Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Managing HIV with diabetes
MDedge Hematology and Oncology
Telemedicine payment expansion?
MDedge Hematology and Oncology
Bundle pay plan didn’t save money
MDedge Hematology and Oncology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Hematology and Oncology
Is fibromyalgia one disorder – or two?
MDedge Hematology and Oncology
Is fish oil’s heart benefit a fish tale?
MDedge Hematology and Oncology
Blood pressure meds cut cognitive impairment risk
MDedge Hematology and Oncology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Hematology and Oncology
CTCs linked to late recurrence in HER2–, HR+ breast cancer
MDedge Hematology and Oncology
Free skin cancer screening highlights need
MDedge Hematology and Oncology